vs
Side-by-side financial comparison of AMREP CORP. (AXR) and CRYO CELL INTERNATIONAL INC (CCEL). Click either name above to swap in a different company.
AMREP CORP. is the larger business by last-quarter revenue ($14.6M vs $7.8M, roughly 1.9× CRYO CELL INTERNATIONAL INC). AMREP CORP. runs the higher net margin — 21.6% vs -48.7%, a 70.3% gap on every dollar of revenue. On growth, AMREP CORP. posted the faster year-over-year revenue change (93.8% vs -2.3%). AMREP CORP. produced more free cash flow last quarter ($5.4M vs $1.2M). Over the past eight quarters, CRYO CELL INTERNATIONAL INC's revenue compounded faster (-0.1% CAGR vs -13.6%).
AMREP Corporation is a real estate and media services company based in Princeton, New Jersey, in the United States. It was founded in 1961 as The American Realty and Petroleum Corporation.
Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.
AXR vs CCEL — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $14.6M | $7.8M |
| Net Profit | $3.1M | $-3.8M |
| Gross Margin | — | 77.9% |
| Operating Margin | 20.6% | -50.6% |
| Net Margin | 21.6% | -48.7% |
| Revenue YoY | 93.8% | -2.3% |
| Net Profit YoY | 338.9% | -105.1% |
| EPS (diluted) | $0.58 | $-0.46 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $14.6M | — | ||
| Q4 25 | $9.4M | $7.8M | ||
| Q3 25 | $17.9M | $7.8M | ||
| Q2 25 | $11.2M | $7.9M | ||
| Q1 25 | $7.5M | $8.0M | ||
| Q4 24 | $11.9M | $8.0M | ||
| Q3 24 | $19.1M | $8.1M | ||
| Q2 24 | $19.5M | $8.0M |
| Q1 26 | $3.1M | — | ||
| Q4 25 | $1.2M | $-3.8M | ||
| Q3 25 | $4.7M | $749.4K | ||
| Q2 25 | $3.9M | $355.8K | ||
| Q1 25 | $717.0K | $282.9K | ||
| Q4 24 | $4.0M | $-1.9M | ||
| Q3 24 | $4.1M | $1.1M | ||
| Q2 24 | $4.1M | $655.8K |
| Q1 26 | — | — | ||
| Q4 25 | — | 77.9% | ||
| Q3 25 | — | 77.0% | ||
| Q2 25 | — | 76.6% | ||
| Q1 25 | — | 75.1% | ||
| Q4 24 | — | 78.4% | ||
| Q3 24 | — | 73.6% | ||
| Q2 24 | — | 74.8% |
| Q1 26 | 20.6% | — | ||
| Q4 25 | 11.9% | -50.6% | ||
| Q3 25 | 34.4% | 24.3% | ||
| Q2 25 | 31.7% | 18.8% | ||
| Q1 25 | 5.7% | 13.3% | ||
| Q4 24 | 26.4% | -1.5% | ||
| Q3 24 | 26.1% | 17.2% | ||
| Q2 24 | 23.9% | 17.3% |
| Q1 26 | 21.6% | — | ||
| Q4 25 | 12.8% | -48.7% | ||
| Q3 25 | 26.3% | 9.6% | ||
| Q2 25 | 34.8% | 4.5% | ||
| Q1 25 | 9.5% | 3.5% | ||
| Q4 24 | 33.9% | -23.2% | ||
| Q3 24 | 21.3% | 13.0% | ||
| Q2 24 | 21.2% | 8.2% |
| Q1 26 | $0.58 | — | ||
| Q4 25 | $0.22 | $-0.46 | ||
| Q3 25 | $0.87 | $0.09 | ||
| Q2 25 | $0.73 | $0.04 | ||
| Q1 25 | $0.13 | $0.03 | ||
| Q4 24 | $0.75 | $-0.23 | ||
| Q3 24 | $0.76 | $0.13 | ||
| Q2 24 | $0.77 | $0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $50.0M | $3.3M |
| Total DebtLower is stronger | $21.0K | $8.4M |
| Stockholders' EquityBook value | $139.4M | $-18.6M |
| Total Assets | $143.9M | $61.7M |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $50.0M | — | ||
| Q4 25 | $44.6M | $3.3M | ||
| Q3 25 | $48.9M | $3.2M | ||
| Q2 25 | $39.5M | $4.4M | ||
| Q1 25 | $36.9M | $3.5M | ||
| Q4 24 | $40.1M | $3.5M | ||
| Q3 24 | $40.4M | $2.1M | ||
| Q2 24 | $29.7M | $1.5M |
| Q1 26 | $21.0K | — | ||
| Q4 25 | $23.0K | $8.4M | ||
| Q3 25 | $25.0K | $8.4M | ||
| Q2 25 | $26.0K | $8.4M | ||
| Q1 25 | $29.0K | $8.5M | ||
| Q4 24 | $32.0K | $8.5M | ||
| Q3 24 | $34.0K | $8.5M | ||
| Q2 24 | $35.0K | $8.5M |
| Q1 26 | $139.4M | — | ||
| Q4 25 | $136.0M | $-18.6M | ||
| Q3 25 | $134.7M | $-14.8M | ||
| Q2 25 | $130.0M | $-15.6M | ||
| Q1 25 | $126.0M | $-14.7M | ||
| Q4 24 | $125.1M | $-13.2M | ||
| Q3 24 | $122.2M | $-9.6M | ||
| Q2 24 | $118.0M | $-10.7M |
| Q1 26 | $143.9M | — | ||
| Q4 25 | $140.1M | $61.7M | ||
| Q3 25 | $140.7M | $63.2M | ||
| Q2 25 | $133.8M | $64.4M | ||
| Q1 25 | $128.9M | $64.4M | ||
| Q4 24 | $129.1M | $64.7M | ||
| Q3 24 | $127.0M | $62.9M | ||
| Q2 24 | $122.8M | $62.6M |
| Q1 26 | 0.00× | — | ||
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $5.4M | $1.3M |
| Free Cash FlowOCF − Capex | $5.4M | $1.2M |
| FCF MarginFCF / Revenue | 37.0% | 15.5% |
| Capex IntensityCapex / Revenue | 0.1% | 0.9% |
| Cash ConversionOCF / Net Profit | 1.72× | — |
| TTM Free Cash FlowTrailing 4 quarters | $20.2M | $5.2M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $5.4M | — | ||
| Q4 25 | $-4.3M | $1.3M | ||
| Q3 25 | $9.5M | $2.5M | ||
| Q2 25 | $10.2M | $707.0K | ||
| Q1 25 | $-3.2M | $954.1K | ||
| Q4 24 | $-182.0K | $2.2M | ||
| Q3 24 | $10.7M | $2.4M | ||
| Q2 24 | $10.7M | $1.8M |
| Q1 26 | $5.4M | — | ||
| Q4 25 | $-4.3M | $1.2M | ||
| Q3 25 | $9.5M | $2.5M | ||
| Q2 25 | $9.7M | $644.6K | ||
| Q1 25 | $-3.3M | $892.0K | ||
| Q4 24 | $-268.0K | $2.1M | ||
| Q3 24 | $10.7M | $2.3M | ||
| Q2 24 | $10.3M | $21.5K |
| Q1 26 | 37.0% | — | ||
| Q4 25 | -45.9% | 15.5% | ||
| Q3 25 | 53.2% | 31.9% | ||
| Q2 25 | 86.4% | 8.1% | ||
| Q1 25 | -43.4% | 11.2% | ||
| Q4 24 | -2.3% | 26.8% | ||
| Q3 24 | 55.8% | 27.9% | ||
| Q2 24 | 52.5% | 0.3% |
| Q1 26 | 0.1% | — | ||
| Q4 25 | 0.6% | 0.9% | ||
| Q3 25 | 0.1% | 0.5% | ||
| Q2 25 | 5.2% | 0.8% | ||
| Q1 25 | 0.3% | 0.8% | ||
| Q4 24 | 0.7% | 0.1% | ||
| Q3 24 | 0.2% | 2.3% | ||
| Q2 24 | 2.3% | 21.8% |
| Q1 26 | 1.72× | — | ||
| Q4 25 | -3.54× | — | ||
| Q3 25 | 2.03× | 3.38× | ||
| Q2 25 | 2.63× | 1.99× | ||
| Q1 25 | -4.51× | 3.37× | ||
| Q4 24 | -0.05× | — | ||
| Q3 24 | 2.63× | 2.32× | ||
| Q2 24 | 2.59× | 2.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
